Saniona: Recruitment to phase III study in Mexico completed
Research Note
2018-02-01
11:37
Earlier today, Saniona announced that the recruitment of patients (n=372) in the phase III study with tesofensine in obese patients has been completed. The trial is expected to be finalized in 2018 followed by top-line data to be presented in early 2019.
AH
Anders Hedlund
Disclosures and disclaimers